Ki Park

Ki Park, M.D.

Associate Professor

Department: MD-CARDIOLOGY
Business Email: kep6@ufl.edu

About Ki Park

Ki Park, MD, is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at the University of Florida. In addition to her professorship role, she is the Director of Women’s Cardiovascular Health Services at UF Health.

Dr. Park received a bachelor’s degree in microbiology at the University of Florida. She also completed her internal medicine residency, general cardiology fellowship and interventional cardiology fellowship at the University of Florida College of Medicine. During her fellowship training, she also completed a Cardiovascular Cell Therapy Research Network Fellowship and earned a master of science in translational science through the APPCI program. In 2010, she received the UF Department of Medicine’s Excellence in Research Award as well as the American Heart Association’s Women in Cardiology Trainee Award for Excellence.

Dr. Park partners with other UF Health cardiologists to create a dedicated team for targeted cardiovascular women’s care in Gainesville and throughout Florida. She has a number of research studies focused on women-specific cardiology care to help offer the latest technologies and research to her patients.

Accomplishments

Semi-finalist
2020 · Women As One Escalator Awards
Stop Heart Disease Researcher of the Year
2020 · Florida Heart Research Foundation
Exemplary Mentor Award
2019 · University of Florida Department of Medicine
Exemplary Teacher Award
2019 · University of Florida Department Of Medicine
Exemplary Teacher Award
2018-2020 · University of Florida College of Medicine
Top Quality Award
2016-2017 · University of Florida Department Of Medicine
Excellence in Research Award
2010 · University of Florida Department of Medicine
Women in Cardiology Trainee Award
2010 · American Heart Association
Women In Cardiology Trainee Award for Excellence
2010 · American Heart Association

Teaching Profile

Courses Taught
2018
MDT7090 Elective Topics
2021
BMS6633 The Cv System

Board Certifications

  • Cardiovascular Disease
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal medicine
  • Interventional Cardiology
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Cardiology
Subspecialties
  • Cardiovascular Disease
  • Interventional Cardiology

Research Profile

Research interests include sex differences in coronary and structural interventions as well as heart disease in women and in pregnancy.

Publications

2021
Assisted Reproductive Technologies and Their Association With Adverse Pregnancy Outcomes and Long-Term Cardiovascular Disease: Implications for Counseling Patients
Current Treatment Options in Cardiovascular Medicine. 23(8) [DOI] 10.1007/s11936-021-00932-3.
2021
Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5.
Journal of the American College of Cardiology. 77(14):1823-1834 [DOI] 10.1016/j.jacc.2021.02.025. [PMID] 33832608.
2021
Coronary Artery Bypass: Review of Surgical Techniques and Impact on Long-Term Revascularization Outcomes.
Cardiology and therapy. 10(1):89-109 [DOI] 10.1007/s40119-021-00211-z. [PMID] 33515370.
2021
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.
Circulation. 143(7):624-640 [DOI] 10.1161/CIRCULATIONAHA.120.052008. [PMID] 33191769.
2021
Ischemic Heart Disease in Pregnancy.
Cardiology clinics. 39(1):91-108 [DOI] 10.1016/j.ccl.2020.09.006. [PMID] 33222818.
2021
The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease.
European cardiology. 16 [DOI] 10.15420/ecr.2021.18. [PMID] 34603511.
2021
Variations in Awareness of Association Between Adverse Pregnancy Outcomes and Cardiovascular Risk by Specialty.
Cardiology and therapy. 10(2):577-592 [DOI] 10.1007/s40119-021-00220-y. [PMID] 34043209.
2020
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women.
JAMA cardiology. 5(12):1390-1398 [DOI] 10.1001/jamacardio.2020.4097. [PMID] 32936228.
2020
Circulating SHBG (Sex Hormone-Binding Globulin) and Risk of Ischemic Stroke: Findings From the WHI.
Stroke. 51(4):1257-1264 [DOI] 10.1161/STROKEAHA.120.028905. [PMID] 32078494.
2020
Comparison of 30-Day Unplanned Readmissions to the Index Versus Nonindex Hospital After Percutaneous Coronary Intervention.
The American journal of cardiology. 125(9):1287-1294 [DOI] 10.1016/j.amjcard.2020.01.051. [PMID] 32151435.
2020
Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes.
Clinical cardiology. 43(6):553-559 [DOI] 10.1002/clc.23374. [PMID] 32304143.
2020
Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation.
Journal of women's health (2002). 29(9):1150-1159 [DOI] 10.1089/jwh.2019.8074. [PMID] 32667846.
2020
Home-Based Cardiac Rehabilitation (HBCR) In Post-TAVR Patients: A Prospective, Single-Center, Cohort, Pilot Study.
Cardiology and therapy. 9(2):541-548 [DOI] 10.1007/s40119-020-00186-3. [PMID] 32535753.
2020
Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy.
Open heart. 7(2) [DOI] 10.1136/openhrt-2020-001273. [PMID] 32763966.
2020
Sex-Based Differences in Coronary and Structural Percutaneous Interventions.
Cardiology and therapy. 9(2):257-273 [DOI] 10.1007/s40119-020-00176-5. [PMID] 32440761.
2020
Temporal Trends in Pregnancy-Associated Stroke and Its Outcomes Among Women With Hypertensive Disorders of Pregnancy.
Journal of the American Heart Association. 9(15) [DOI] 10.1161/JAHA.120.016182. [PMID] 32750300.
2019
Ischemic Heart Disease in Women
. 3(3):305-315
2019
Long QT Syndrome: A Comprehensive Review of the Literature and Current Evidence.
Current problems in cardiology. 44(3):92-106 [DOI] 10.1016/j.cpcardiol.2018.04.002. [PMID] 29784533.
2019
Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women’s Health Initiative).
The American journal of cardiology. 123(10):1620-1625 [DOI] 10.1016/j.amjcard.2019.02.012. [PMID] 30871746.
2018
Non-PCI/CABG therapies for refractory angina.
Trends in cardiovascular medicine. 28(3):223-228 [DOI] 10.1016/j.tcm.2017.10.002. [PMID] 29157949.
2018
Polygenic Risk for Depression Increases Risk of Ischemic Stroke: From the Stroke Genetics Network Study.
Stroke. 49(3):543-548 [DOI] 10.1161/STROKEAHA.117.018857. [PMID] 29438084.
2018
Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience.
Cardiology and therapy. 7(2):191-196 [DOI] 10.1007/s40119-018-0115-0. [PMID] 30109506.
2018
Trends in Cardiovascular Disease Risk in the US, 1999-2014
American Journal of Preventive Medicine. 55(3):384-388 [DOI] 10.1016/j.amepre.2018.04.025.
2017
Comparison of Different Invasive Hemodynamic Measurements as a Prediction Tool for Mortality after Transcatheter Aortic Valve Replacement in Men: A Retrospective Observational Study.
Cardiology and therapy. 6(2):251-259 [DOI] 10.1007/s40119-017-0095-5. [PMID] 28667514.
2017
Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study).
Cardiology and therapy. 6(1):81-88 [DOI] 10.1007/s40119-016-0081-3. [PMID] 28044265.
2017
Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?
Cardiology and therapy. 6(1):133-138 [DOI] 10.1007/s40119-016-0077-z. [PMID] 28044267.
2016
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
Texas Heart Institute journal. 43(4):291-6 [DOI] 10.14503/THIJ-15-5341. [PMID] 27547135.
2016
Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs Men
Current Pharmaceutical Design. 22(25):3871-3876
2015
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child
Cardiovascular Drugs and Therapy. 29(4):391-401
2015
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.
Cardiovascular drugs and therapy. 29(4):391-401 [DOI] 10.1007/s10557-015-6597-2. [PMID] 26037616.
2015
Assessing Cardiovascular Risk in Women- Looking Beyond Traditional Risk Factors
Trends in Cardiovascular Medicine. 25(2):152-153
2015
Assessing cardiovascular risk in women: looking beyond traditional risk factors.
Trends in cardiovascular medicine. 25(2):152-3 [DOI] 10.1016/j.tcm.2014.10.024. [PMID] 25468290.
2014
A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.
Regenerative medicine. 9(6):793-7 [DOI] 10.2217/rme.14.57. [PMID] 25431915.
2014
Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.
Journal of interventional cardiology. 27(1):80-5 [DOI] 10.1111/joic.12088. [PMID] 24383617.
2013
Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events.
Cleveland Clinic journal of medicine. 80(5):318-26 [DOI] 10.3949/ccjm.80a.12146. [PMID] 23636924.
2013
Electromechanical Assessment of Myocardial Function (Noga) Is Associated With Exercise Improvement in Patients Treated With Autologous Stem Cell Therapy for Refractory Angina
Journal of the American College of Cardiology. 61
2013
Electromechanical Assessment of Myocardial Function Is Associated With Improvement in Ejection Fraction in Patients Treated With Autologous Stem Cell Therapy for Ischemic Cardiomyopathy
Circulation. 128(22, S)
2012
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines.
Clinical cardiology. 35(2):93-100 [DOI] 10.1002/clc.20974. [PMID] 22028212.
2011
Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines.
Journal of the American College of Cardiology. 57(10):1190-9 [DOI] 10.1016/j.jacc.2010.10.030. [PMID] 21371635.
2011
Microvascular dysfunction:what have we learned from WISE?
Expert Review of Cardiovascular Therapy. 9(12):1491-1494
2010
Bone marrow-derived cells and hypertension.
Expert review of cardiovascular therapy. 8(8):1139-48 [DOI] 10.1586/erc.10.105. [PMID] 20670191.
2010
Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in review.
Cleveland Clinic journal of medicine. 77 Suppl 3:S40-5 [DOI] 10.3949/ccjm.77.s3.07. [PMID] 20622075.

Grants

May 2021 ACTIVE
214 Fund Park Payroll Operating Account
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Aug 2020 – Jul 2021
2020 Stop Heart Disease Researcher of the Year Award
Role: Principal Investigator
Funding: FL HEART RESEARCH FOU
Sep 2017 ACTIVE
Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
Role: Project Manager
Funding: US ARMY MED RES ACQUISITION
Apr 2017 – Apr 2021
Womens Heart Attack Research Program (HARP)
Role: Principal Investigator
Funding: NEW YORK UNIVERSITY SCHOOL OF MEDICINE via AMER HEART ASSOCIATION
Apr 2017 – Apr 2021
Womens Heart Attack Research Program (HARP)
Role: Principal Investigator
Funding: NEW YORK UNIVERSITY SCHOOL OF MEDICINE via AMER HEART ASSOCIATION
Jul 2007 – Aug 2016
Clinical and Translational Science Institute
Role: Project Manager
Funding: UF RESEARCH FOU

Education

Fellowship – Cardiovascular Medicine
2010 · University of Florida
Master of Science – Translational Science
2009-2011 · University of Florida
Research Fellowship – Cardiovascular Medicine
2009-2010 · University of Florida
Residency – Internal Medicine
2006-2009 · University of Florida
Medical Degree
2002-2006 · University of Florida

Contact Details

Emails:
Business:
kep6@ufl.edu
Addresses:
Business Mailing:
PO Box 100288
GAINESVILLE FL 32610
Business Street:
PO BOX 100288
DIVISION OF CARDIOVASCULAR MEDICINE
GAINESVILLE FL 326100277